circadian clock raises a handful of sensible questions. This page answers them in order, starting with the fundamentals and moving to applications.
Reviewed 2026-04-20. Anything still debated is marked as such rather than presented as settled.
SR9009 is a synthetic small molecule studied as an agonist of REV-ERB nuclear receptors. REV-ERB alpha and REV-ERB beta help regulate circadian rhythms and metabolic gene expression. In laboratory research, SR9009 has been used to probe how these receptors affect skeletal muscle, liver, and adipose tissue. The compound was identified in academic drug-discovery work and is often described in scientific literature by its chemical name and research code. It is not an approved medicine, and human clinical data remain limited or absent.
SR9009 binds REV-ERB receptors and alters their repressive activity on target genes. This action can change transcription of genes involved in lipid handling, glucose metabolism, and mitochondrial function. In rodent studies, treated animals have shown changes in muscle oxidative capacity and exercise performance, though effects vary by dose, duration, and model. The precise molecular steps connecting receptor binding to whole-body outcomes are still an active area of investigation. Findings in animals do not automatically translate to humans.
Because REV-ERB receptors are core clock components, SR9009 has been examined for effects on daily rhythms as well as metabolism. Research has explored whether the compound can shift or reinforce circadian gene expression in tissues such as liver and muscle. Some studies report improved metabolic markers in obese or diabetic mice, while others show context-dependent responses. Questions remain about which effects are direct, which are secondary to timing, and how they might differ across species.
SR9009 is generally described as poorly soluble in water and more soluble in organic solvents such as dimethyl sulfoxide and ethanol. Stock solutions are commonly prepared in an organic solvent before dilution into an aqueous buffer or vehicle. Precipitation can occur if the organic fraction is reduced too quickly or if the final concentration exceeds the compound's solubility limit. Sonication or gentle warming may aid dissolution in some protocols, but excessive heat can promote degradation. Container material and pH can also influence observed solubility.
For long-term storage, SR9009 is typically kept as a solid at low temperature, protected from moisture and light. Desiccated conditions limit hydrolysis, while opaque containers reduce photochemical breakdown. Solutions are less stable than solids and are often stored frozen in aliquots to avoid repeated freeze-thaw cycles. Stability data are not standardized across all suppliers, so users should rely on certificate-of-analysis information when available. Degradation may appear as color change, precipitate, or decreased chromatographic purity.
Laboratory identification of SR9009 typically relies on chromatographic separation coupled to mass spectrometry, often with ultraviolet detection as a secondary check. Nuclear magnetic resonance spectroscopy can confirm molecular structure when a reference standard is available. Because many suppliers sell the compound as a research chemical, independent identity testing is important for experimental reproducibility. A single retention time is not sufficient proof of identity, especially when related compounds may be present. Purity assessments usually report a percentage based on area normalization.
| Property | Value | Notes |
|---|---|---|
| Chemical class | Synthetic REV-ERB agonist | Small-molecule nuclear receptor ligand |
| Appearance | Off-white to pale yellow solid | Typical for research-grade powder |
| Solubility class | Soluble in DMSO; low water solubility | Common stock solutions use organic solvent |
| Typical stock solvent | Dimethyl sulfoxide | Used for laboratory assays |
| Common analytical method | HPLC with UV or mass detection | Used for identity and purity checks |
Most published work on SR9009 consists of preclinical studies. It is widely sold as a research chemical, a category that does not imply safety, efficacy, or pharmaceutical-grade quality. Sports anti-doping organizations have listed SR9009 as a prohibited substance, and its presence in an athlete sample can lead to sanctions. Legal status differs by country; in several jurisdictions it is not approved for human consumption and may be treated as an unapproved new drug.
SR9009 is a synthetic small molecule studied as an agonist of the nuclear receptors REV-ERBα and REV-ERBβ. It is not a steroid, peptide, or natural hormone. In scientific literature, it appears under the code SR9009 and in non-scientific contexts as Stenabolic. The compound was identified through chemical screening efforts aimed at targeting circadian clock components. Its status remains investigational, and no regulatory agency has approved it as a human medicine.
REV-ERB proteins help regulate daily cycles in gene expression, including genes tied to lipid and glucose metabolism. SR9009 binds these receptors and alters their activity in cell and animal experiments. Consequences observed in rodents include changes in skeletal muscle oxidative capacity, blood lipid levels, and exercise performance. The precise chain from receptor occupancy to whole-body effects is still an active area of study. Human responses cannot be assumed from rodent data.
Regulatory treatment of SR9009 varies by country and region. It is not approved as a pharmaceutical, and several jurisdictions restrict its sale for human consumption. Some authorities classify it as a research chemical, a prescription-only substance, or a prohibited performance-enhancing agent in sport. Purchasers may encounter certificates of analysis, but these documents do not guarantee identity, purity, or legality. In research settings, institutional safety reviews and controlled procurement help ensure that materials are handled under appropriate oversight. The absence of harmonized rules means that legal status can change and requires verification.
Analytical identification of SR9009 typically relies on liquid chromatography coupled with tandem mass spectrometry. In biological samples, researchers first separate the compound from matrix components using protein precipitation, liquid-liquid extraction, or solid-phase extraction. High-performance liquid chromatography with ultraviolet detection and nuclear magnetic resonance spectroscopy can support structural confirmation of reference materials. Because SR9009 is a small, relatively lipophilic molecule, reverse-phase columns and acidic mobile phases are common. Laboratories often include isotope-labeled internal standards to improve quantification and to correct for ion suppression.
== Structure–activity relationship == Even though μ-opioid receptor (MOR) targeting drugs have been used for a long time, not much is known about the structure-activity relationship and the ligand-receptor interactions on the basis of well-defined biological effects on receptor activation or inhibition. Also, the distinction in the receptor-ligand interaction patterns of agonists and antagonists is not known for sure. One theory states that the morphinans biological activity could be determined by the size of the N-substituents. For example, antagonists usually have larger substituents, such as allyl- or cyclopropyl methyl at the morphinan nitrogen, while agonists generally contain a methyl group. On the other hand, agonist activity is also shown in ligands with larger groups at the morphinan nitrogen, and therefore this hypothesis is challenged.
==== Subcultural model ==== Historically, addiction has been viewed from the etic perspective, defining users through the pathology of their condition. As reports of drug use rapidly increased, the cultural model found application in anthropological research exploring western drug subculture practices. The approach evolved from the ethnographic exploration into the lived experiences and subjectivities of 1960s and 70s drug subcultures. The publication "Taking care of business", by Edward Preble and John J. Casey, documented the daily lives of New York street-based intravenous heroin users in detail, providing insight into the dynamic social worlds and activities that surrounded their drug use. Singer writes that this work reframed substance use as a social phenomenon rather than a matter of immorality or deviance. The prevailing culture can influence drug-taking behaviors, along with the physical and psychological effects of the drug. To marginalized individuals, drug subcultures can provide social connection, symbolic meaning, and socially constructed purpose that they may feel is unattainable through conventional means. On this account, a biosocial approach is required for a holistic understanding of addiction.
==== Light-enhanced ==== Plasmonic effects have been studied quite extensively. Until recently, there have not been studies investigating the oxidative catalytic enhancement of a nanostructure via excitation of its surface plasmon resonance. The defining feature for enhancing the oxidative catalytic ability has been identified as the ability to convert a beam of light into the form of energetic electrons that can be transferred to adsorbed molecules. The implication of such a feature is that photochemical reactions can be driven by low-intensity continuous light coupled with thermal energy. The coupling of low-intensity continuous light and thermal energy has been performed with silver nanocubes. The important feature of silver nanostructures that are enabling for photocatalysis is their nature to create resonant surface plasmons from light in the visible range. The addition of light enhancement enabled the particles to perform to the same degree as particles that were heated up to 40 K greater. This is a profound finding when noting that a reduction in temperature of 25 K can increase the catalyst lifetime by nearly tenfold, when comparing the photothermal and thermal process.
=== An–Av === Gloria Long Anderson (born 1938), American chemist, pioneer of nuclear magnetic resonance spectroscopy Christian B. Anfinsen (1916–1995), American chemist known for work on ribonuclease, 1972 Nobel Prize in Chemistry Andrea Angel (1877–1917), English chemist known for work on explosives Angelo Angeli (1864–1931), Italian chemist who studied nitrogen compounds such as hydrazoic acid Octavio Augusto Ceva Antunes (died 2009), Brazilian chemist, consultant for the production of anti-HIV drugs Anthony Joseph Arduengo, III (born 1952), American chemist known for chemical compounds with unusual valency Johan August Arfwedson (1792–1841), Swedish chemist who discovered lithium Anton Eduard van Arkel (1893–1976), Dutch chemist who developed a method for preparing pure titanium and other metals Svante Arrhenius (1859–1927), Swedish chemist, one of the founders of physical chemistry, he used physical chemistry to estimate the effect of atmospheric carbon dioxide the Earth's increasing surface temperature; Nobel Prize in Chemistry, 1903 Valerie Ashby (born 1965/1966), American chemist known for work on functionalized diene monomers and polymers Barbara Askins (born 1939), American chemist known for inventing a method to enhance underexposed photographic negatives Larned B.
Sources: en.wikipedia.org
== Categories == The two basic categories used to classify fish protein powders are dependent on the levels of protein, fat, mineral and carbohydrate contained in the powder. The minerals are mostly naturally occurring, organic complexes of magnesium, calcium and phosphorus. The spray drying process may utilize other minerals and carbohydrates to improve flow characteristics of the final product thus altering the natural balance. Powders will all have a residual moisture content in the 4-8% range.
junk DNA Any DNA sequence that appears to have no known biological function, or which acts in a way that has no positive or a net negative effect on the fitness of the genome in which it is located. The term was once more broadly used to refer to all non-coding DNA, though much of this was later discovered to have a function; in modern usage it typically refers to broken or vestigial sequences and selfish genetic elements, including introns, pseudogenes, intergenic DNA, and fragments of transposons and retroviruses, which together constitute a large proportion of the genomes of most eukaryotes. Despite not contributing productively to the host organism, these sequences are able to persist indefinitely inside genomes because the disadvantages of continuing to copy them are too small to be acted upon by natural selection.
The meeting went from bad to worse, with Thiệu having a meltdown as he broke down in tears and hysterically accused Kissinger of plotting with the Soviet Union and China to betray him, saying he could never accept this peace agreement. Kissinger's statement that "Had we wanted to see you out, there would have been many easier ways by which we could have accomplished this" did not improve the mood. Thiệu later stated that he wanted to punch Kissinger in the face at that meeting. Thiệu refused to sign the peace agreement and demanded very extensive amendments that, as Kissinger reported to Nixon, "verge on insanity". Nixon ordered Kissinger to "push Thiệu as far as possible", but Thiệu refused to sign the peace agreement. Thiệu refused to see Kissinger the next day. Kissinger told one of Thieu's aides, Hoang Duc Nha, on the phone: "I am the special envoy of the President of the United States of America. You know I cannot be treated as an errand boy". Nha replied: "We never considered you an errand boy, but if that's what you think you are, there's nothing I can do about it". As Kissinger returned to Washington, one of his aides recalled: "In twenty-four hours, the bottom fell out". Though Nixon had initially supported Kissinger against Thiệu, two of his most influential advisers, namely his chief of staff, H.R. Haldeman and the Domestic Affairs Adviser John Ehrlichman, urged him to reconsider, arguing that Kissinger had given away too much and that Thiệu's objections had merit.
For example, an elevated neutrophil count (neutrophilia) is associated with bacterial infection, inflammation, and myeloproliferative disorders, while a decreased count (neutropenia) may occur in individuals who are undergoing chemotherapy or taking certain drugs, or who have diseases affecting the bone marrow. Neutropenia can also be caused by some congenital disorders and may occur transiently after viral or bacterial infections in children. People with severe neutropenia and clinical signs of infection are treated with antibiotics to prevent potentially life-threatening disease.
== Interactions == No interactions in humans have been described. Combining racecadotril with an ACE inhibitor can theoretically increase the risk for angioedema. Racecadotril and its main metabolites neither inhibit nor induce the liver enzymes CYP1A2, CYP2C9, CYP2C19, CYP2D6, and CYP3A4. They also do not induce UGT enzymes. This means that racecadotril has a low potential for pharmacokinetic interactions.
Sources: en.wikipedia.org
== Contraindications == Sulfanilamide is contraindicated in those known to be hypersensitive to sulfonamides, in nursing mothers, during pregnancy near term, and in infants less than two months of age.
=== Obstructive sleep apnea === Abdominal obesity is an important risk factor for obstructive sleep apnea, as increased abdominal fat can place pressure on the airway and narrow it. This can lead to reduced lung volumes during sleep. Higher waist circumference and waist-to-hip ratio are associated with obstructive sleep apnea, even in individuals whose body mass index is only in the overweight range.
== P == Pacinian corpuscle A type of rapidly adapting mechanoreceptor located deep in the skin, responsible for detecting vibration and pressure. Pain An unpleasant sensory and emotional experience associated with actual or potential tissue damage. In neuroscience, pain is studied through nociception, pain pathways, and perception. Paralysis The loss of voluntary muscle function, often caused by damage to the brain, spinal cord, or peripheral nerves. Paraneoplastic syndrome A rare disorder triggered by an immune response to cancer that affects the nervous system. Can lead to sensory, motor, or cognitive symptoms. Parietal lobe A region of the cerebral cortex located near the top and back of the brain, involved in processing somatosensory information, spatial orientation, and body awareness. Parkinson’s disease A neurodegenerative disorder characterized by tremors, rigidity, bradykinesia, and postural instability. Caused by loss of dopaminergic neurons in the substantia nigra. Parvocellular pathway A visual processing stream originating in small ganglion cells of the retina, responsible for high-acuity and color vision. Projects to the lateral geniculate nucleus. Periaqueductal gray (PAG) A midbrain region involved in pain modulation, defensive behavior, and autonomic regulation. Contains opioid receptors and descending pain control pathways. Peripheral nervous system (PNS) All nerves and ganglia outside the brain and spinal cord. It includes sensory and motor neurons as well as autonomic nerves. Periventricular Located near or surrounding the brain’s ventricular system.
=== Acute care and monitoring === Acute care and monitoring (ACM) is based out of Lafayette, Colorado and produces non-invasive sensors and monitoring products, used for patient monitoring in the hospital and home settings. It has absorbed the portfolios of acquired companies, including Covidien, Nellcor, Somanetics, Aspect Medical Systems, Oridion Medical and Zephyr Technology. This business unit produces pulse oximetry, capnography, and bispectral index sensors, patient monitors, remote patient monitoring software, and electronic medical record connectivity software.
ModDB ( MOD-dee-BEE) is a website that focuses on general video game modding. It was founded in 2002 by Scott "INtense!" Reismanis. As of August 2026, the ModDB site has received over 2 billion views, has more than 36,000 modifications registered, and has hosted more than 382 million downloads. A spin-off website, IndieDB, was launched in 2010 and focuses on indie games and news. The website has retained a mostly traditional user interface, with its overall layout, dark red theme, and design remaining largely unchanged since 2008.
Sources: en.wikipedia.org
SR9009 is a synthetic research compound that acts on REV-ERB nuclear receptors. It is not approved for human use and is sold only as a research chemical. Its effects have been studied mainly in cells and rodents.
It binds REV-ERB alpha and REV-ERB beta and changes the expression of genes tied to metabolism and circadian rhythm. These changes can affect mitochondria and energy use in animal models. The exact chain from receptor binding to physiological outcome is still being mapped.
No reliable human trials show that SR9009 improves athletic performance. Some rodent studies report endurance changes, but these results are not proof of human benefit. Its use in sport is prohibited, and quality and safety data are lacking.
Liquid chromatography with mass spectrometry is a common approach. Ultraviolet detection and nuclear magnetic resonance can support identification when suitable standards are available.